Over the years, there has been a lot of publicity and press on the benefits of chromium. It has been touted for weight loss, curing diabetes, lowering cholesterol, and improving testosterone levels. It seems that every few years a new “formula” appears that guarantees results, and many patients have had …

Beta-blocker use in patients with T2DM and established CV risk factors associated with increased risk of CV events and severe hypoglycemia, according to recent study.

The growth of diabetes in the United States may be slowing, but it is still increasing. Just how bad can it get?

Extra virgin olive oil, like statins, promotes lipid lowering in people with diabetes who have dyslipidemia.

Serum concentration levels of both chromium and manganese metals are altered in people with and without diabetes.

Serum bilirubin is inversely correlated with diabetic retinopathy predicting progression of retinopathy over time.

Amin Zayani is the founder and CEO of MedAngel. He works with his team of engineers, pharmacists and designers on improving drugs safety for patients who live with diabetes and rely on temperature sensitive drugs like insulin. Their solution, MedAngel ONE brings a simple and easy to use temperature monitor that is compatible with smartphones and supports all FDA-approved insulins and many more medications.

What percent of your patients with diabetes fail to meet national treatment targets for glycemic, blood pressure, or cholesterol control? a) >50% b) >75% c) < 50% d) 25% Follow the link to see how you and your colleagues compare.

Your patient has been systematically titrating his basal insulin dose for the last 6 months; his daily dose is NPH .90 U/kg/day. Despite his good efforts, you decide it would be prudent to add a prandial insulin dose to his treatment regimen. Which of the following scenarios might lead you to this conclusion? A) A1C=7.4%, FPG<130 mg/dl, PPG>180 mg/dl B) A1C=7.0%, FPG<130 mg/dl, PPG<180 mg/dl C) A1C=7.0%, FPG<120mg/dl, PPG<160mg/dl D) A1C=6.8%, FPG<120 mg/dl, PPG<160 mg/dl Follow the link to see if you got it right.

Amin Zayani talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about his new product to give diabetes patients who use insulin peace of mind.